MRK earnings call for the period ending March 31, 2019.
News & Analysis: Merck & Co.
Here's why the big drugmaker topped Wall Street's top- and bottom-line estimates for the first quarter.
If you thought Monday was exciting, wait until you see what's on the slate for the rest of the week.
Drugmakers battle for patients.
Here's how the pharma giant fits in with the latest outbreak and the city's major response.
Which stock wins in a battle between these two big pharmaceutical companies?
Find out why these oncology-focused companies stand out as great opportunities right now.
Is the giant healthcare conglomerate a better pick than the highly focused drugmaker?
Solid fourth-quarter results from the big drugmaker gave investors something to smile about. But there's more to the story.
MRK earnings call for the period ending December 31, 2018.